Visceral neuropathy and intestinal pseudo-obstruction in a murine model of a nuclear inclusion disease.

BACKGROUND & AIMS Intestinal dysmotility is a component of many neurodegenerative disorders, including some characterized by neuronal intranuclear inclusions. PrP-SCA7-92Q transgenic mice phenocopy many aspects of the human polyglutamine neurodegenerative disorder spinocerebellar ataxia type 7 (SCA7). The enteric neuropathology of PrP-SCA7-92Q mice was investigated after observing that they develop signs of intestinal pseudo-obstruction. METHODS Gastrointestinal transit of radio-opaque pellets through presymptomatic and symptomatic PrP-SCA7-92Q mice and nontransgenic littermates was compared. Gross, microscopic, and ultrastructural studies were conducted, along with histologic and whole mount immunohistochemistry, to identify intranuclear inclusions and quantify subsets of enteric neurons. Immunoblot analysis was performed to confirm selective loss of particular neuronal populations. RESULTS A subset of cholinergic enteric ganglion cells in PrP-SCA7-92Q mice harbor nuclear inclusions composed of transgene-derived ataxin-7, which contains a pathogenic polyglutamine expansion. These animals die between 15 and 20 weeks of age with intestinal distension and enterocolitis. Signs of disease are preceded by selective loss of nitric oxide synthase-positive neurons (which lack nuclear inclusions), loss of nerve fibers in the myenteric nerve plexus, and delayed gastrointestinal transit. Cholinergic neurons, including those with inclusions, are spared. CONCLUSIONS PrP-SCA7-92Q mice may be useful models for human intestinal pseudoobstruction, particularly visceral neuropathies with neuronal intranuclear inclusions. Loss of inclusion-free inhibitory neurons supports the hypothesis that inclusions may be neuroprotective or coincidental, as opposed to harbingers of neuron death. Because enteric neuropathology in PrP-SCA7-92Q animals is easily missed by routine histopathology, quantitative immunohistochemical approaches may be required to recognize analogous forms of human enteric neuropathy.

[1]  A. Koeppen,et al.  The pathogenesis of spinocerebellar ataxia , 2008, The Cerebellum.

[2]  J. Woulfe,et al.  Abnormalities of the nucleus and nuclear inclusions in neurodegenerative disease: a work in progress , 2007, Neuropathology and applied neurobiology.

[3]  G. McKnight,et al.  Inhibition of protein kinase A in murine enteric neurons causes lethal intestinal pseudo-obstruction. , 2006, Journal of neurobiology.

[4]  J. Huizinga,et al.  Changes in interstitial cells of Cajal at the deep muscular plexus are associated with loss of distention-induced burst-type muscle activity in mice infected by Trichinella spiralis. , 2005, The American journal of pathology.

[5]  C. Wiley,et al.  Neuronal Intranuclear Inclusion Disease Without Polyglutamine Inclusions in a Child , 2005, Journal of neuropathology and experimental neurology.

[6]  Junko Takahashi-Fujigasaki,et al.  Neuronal intranuclear hyaline inclusion disease , 2003, Neuropathology : official journal of the Japanese Society of Neuropathology.

[7]  S. Shirasawa,et al.  Genetic background modifies intestinal pseudo-obstruction and the expression of a reporter gene in Hox11L1-/- mice. , 2003, Gastroenterology.

[8]  E. Haan,et al.  SUMO-1 marks the nuclear inclusions in familial neuronal intranuclear inclusion disease , 2003, Experimental Neurology.

[9]  純子 藤ヶ崎,et al.  Recruitment of nonexpanded polyglutamine proteins to intranuclear aggregates in neuronal intranuclear hyaline inclusion disease , 2003 .

[10]  C. Ware,et al.  Polyglutamine-Expanded Ataxin-7 Promotes Non-Cell-Autonomous Purkinje Cell Degeneration and Displays Proteolytic Cleavage in Ataxic Transgenic Mice , 2002, The Journal of Neuroscience.

[11]  C. Ware,et al.  Polyglutamine-Expanded Ataxin-7 Antagonizes CRX Function and Induces Cone-Rod Dystrophy in a Mouse Model of SCA7 , 2001, Neuron.

[12]  T. Uchihara,et al.  Neuronal intranuclear hyaline inclusion disease with polyglutamine-immunoreactive inclusions , 2000, Acta Neuropathologica.

[13]  S. Sisodia.  Nuclear Inclusions in Glutamine Repeat Disorders Are They Pernicious, Coincidental, or Beneficial? , 1998, Cell.

[14]  John Q Trojanowski,et al.  Polyglutamine-containing aggregates in neuronal intranuclear inclusion disease , 1998, The Lancet.

[15]  Y. Agid,et al.  Molecular and clinical correlations in autosomal dominant cerebellar ataxia with progressive macular dystrophy (SCA7). , 1998, Human molecular genetics.

[16]  C A Ross,et al.  Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.

[17]  D L Price,et al.  A vector for expressing foreign genes in the brains and hearts of transgenic mice. , 1996, Genetic analysis : biomolecular engineering.

[18]  H. Young,et al.  Chemical coding of neurons in the myenteric plexus and external muscle of the small and large intestine of the mouse , 1996, Cell and Tissue Research.

[19]  P. Tam,et al.  Heterozygous endothelin receptor B (EDNRB) mutations in isolated Hirschsprung disease. , 1996, Human molecular genetics.

[20]  J. Barnett,et al.  Familial visceral neuropathy with neuronal intranuclear inclusions: diagnosis by rectal biopsy. , 1992, Gastroenterology.

[21]  S. M. Sumi,et al.  A familial neuronal disease presenting as intestinal pseudoobstruction. , 1978, Gastroenterology.